Catalyst Wire Dossier Catalyst Wire Dossier
EMA safety_alert · 2006-11-22

Defect in Herceptin vials identified but supply for patients is maintained

View source ↗

Summary

A defect was identified in Herceptin vials, but supply for patients is maintained.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HERCEPTIN (trastuzumab)